NAISHA WILLIAMS: Open Payments
NPI 1649779851 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 31 payments from 11 companies in 2025. Trend: 2023 $175 · 2024 $731 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Novo Nordisk Inc | 5 | $110 |
| Lilly USA, LLC | 3 | $67 |
| Exact Sciences Corporation | 2 | $45 |
| Dexcom, Inc. | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $27 |
| ALK-Abello, Inc | 1 | $20 |
Products named: TRUMENBA, BREZTRI, MOUNJARO, Cologuard Collection Kit, Dexcom G6 Transmitter, Rybelsus, GEMTESA, Ozempic.
Industry payments across MD — which companies pay providers there.
